AB-106

Drug identity checked against registry records

Also recorded as DS-6051b

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Study of AB-106 in Subjects With Advanced NSCLC Harboring ROS1 Fusion GeneNCT04395677NUVBPhase 2Active not recruiting2024-06-07Actual
Phase II Study of AB-106 to Treat Patients With Solid Tumors With NTRK Gene FusionNCT04617054NUVBPhase 2Terminated2024-12-06Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.